Peter M Fischer

发表

Support Tools in Formulation Development for Poorly Soluble Drugs.

Gudrun A Fridgeirsdottir, Robert Harris, Peter M Fischer, 2016, Journal of pharmaceutical sciences.

Discovery and characterization of 2-anilino-4- (thiazol-5-yl)pyrimidine transcriptional CDK inhibitors as anticancer agents.

Peter M Fischer, Wayne Jackson, Campbell McInnes, 2010, Chemistry & biology.

Recent progress in the discovery and development of cyclin-dependent kinase inhibitors

Peter M Fischer, P. Fischer, A. Gianella-Borradori, 2005, Expert opinion on investigational drugs.

Cyclin-dependent kinase 9: a key transcriptional regulator and potential drug target in oncology, virology and cardiology.

Peter M Fischer, Shudong Wang, P. Fischer, 2008, Trends in pharmacological sciences.

Design, synthesis and biological evaluation of 6-pyridylmethylaminopurines as CDK inhibitors.

Paul Workman, Peter M Fischer, Wayne Jackson, 2011, Bioorganic & medicinal chemistry.

Small-molecule inhibitors of MDM2 as new anticancer therapeutics.

Peter M Fischer, Michael P. Dickens, R. Fitzgerald, 2010, Seminars in cancer biology.

Development of a simple and sensitive HPLC-UV method for the simultaneous determination of cannabidiol and Δ(9)-tetrahydrocannabinol in rat plasma.

Peter M Fischer, Cris S Constantinescu, David A Barrett, 2015, Journal of pharmaceutical and biomedical analysis.

The Use of CDK Inhibitors in Oncology: A Pharmaceutical Perspective

Peter M Fischer, P. Fischer, 2004, Cell cycle.

Differential binding of inhibitors to active and inactive CDK2 provides insights for drug design.

Peter M Fischer, Darren Gibson, Campbell McInnes, 2006, Chemistry & biology.

Role of Key Transmembrane Residues in Agonist and Antagonist Actions at the Two Conformations of the Human β1-Adrenoceptor

Peter M Fischer, P. Fischer, S. Hill, 2008, Molecular Pharmacology.

Design, synthesis, and evaluation of 2-methyl- and 2-amino-N-aryl-4,5-dihydrothiazolo[4,5-h]quinazolin-8-amines as ring-constrained 2-anilino-4-(thiazol-5-yl)pyrimidine cyclin-dependent kinase inhibitors.

Peter M Fischer, Wayne Jackson, Campbell McInnes, 2010, Journal of medicinal chemistry.

Inhibitors of Polo-like kinase reveal roles in spindle-pole maintenance

Paul Taylor, Peter M Fischer, Campbell McInnes, 2006, Nature chemical biology.

Strategies for the design of potent and selective kinase inhibitors.

Peter M Fischer, Campbell McInnes, P. Fischer, 2005, Current pharmaceutical design.